Kezar Life Sciences
39 hedge funds and large institutions have $220M invested in Kezar Life Sciences in 2018 Q4 according to their latest regulatory filings, with 10 funds opening new positions, 14 increasing their positions, 9 reducing their positions, and 7 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding in top 10
Funds holding in top 10: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
5% more funds holding
Funds holding: 37 → 39 (+2)
0.15% more ownership
Funds ownership: 4.74% → 4.89% (+0.15%)
Holders
39
Holding in Top 10
3
Calls
–
Puts
–
Top Buyers
| 1 | +$19.3M | |
| 2 | +$7.52M | |
| 3 | +$3.25M | |
| 4 |
Point72 Asset Management
Stamford,
Connecticut
|
+$2.95M |
| 5 |
State Street
Boston,
Massachusetts
|
+$785K |
Top Sellers
| 1 | -$6.44M | |
| 2 | -$5.38M | |
| 3 | -$4.68M | |
| 4 |
SFM
Sphera Funds Management
Tel Aviv,
Israel
|
-$4.53M |
| 5 |
CAM
Cormorant Asset Management
Boston,
Massachusetts
|
-$3.07M |